SCHEMBL30906248

SCHEMBL30906248

CC(C)(C)OC(=O)N1CC2CC1CN2c1ccc2c(c1)CN(C1CCC(=O)NC1=O)C2=O

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 11/20 0.52
▸ CSNK1A1 P48729 4/20 0.47
▸ IKZF2 Q9UKS7 6/20 0.46
▸ GSPT1 P15170 3/20 0.43
▸ SALL4 Q9UJQ4 2/20 0.43
▸ IKZF3 Q9UKT9 2/20 0.43
▸ DDB1 Q16531 2/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ KCNH2 Q12809 1/20 0.43
▸ IKZF1 Q13422 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25933315 1.00 CRBN (0.52) CRBNCSNK1A1IKZF2GSPT1SALL4
SCHEMBL20234915 0.86 CRBN (0.53) CRBNGSPT1IKZF3DDB1
SCHEMBL22873392 0.86 CRBN (0.53) CRBNGSPT1IKZF3DDB1
SCHEMBL30906241 0.86 CRBN (0.47) CRBNCSNK1A1IKZF2GSPT1IKZF3
SCHEMBL20231704 0.86 CRBN (0.53) CRBNCSNK1A1IKZF2GSPT1IKZF3
SCHEMBL30906237 0.85 CRBN (0.45) CRBNCSNK1A1IKZF2GSPT1IKZF3
SCHEMBL30906325 0.81 CRBN (0.54) CRBNCSNK1A1IKZF2GSPT1IKZF3
SCHEMBL20231507 0.81 CRBN (0.54) CRBNCSNK1A1IKZF2GSPT1IKZF3
SCHEMBL20046704 0.81 CRBN (0.56) CRBNCSNK1A1IKZF2DDB1
SCHEMBL31611548 0.81 CRBN (0.56) CRBNCSNK1A1IKZF2DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4598905-A2 CEREBLON-RECRUITING BCL-XL/BCL-2 DUAL DEGRADERS University of Florida Research Foundation, Incorporated (US) 2025-08-13 — — EP disclosed
WO-2024077023-A2 CEREBLON-RECRUITING BCL-XL/BCL-2 DUAL DEGRADERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-04-11 — — WO disclosed
Send feedback